Showing results (1-10 of 250) with videos related to
Sort By:
Pageof 25
Cleveland Clinic Journal of Medicine|January 1, 1992
Experimental therapies for multiple sclerosis: current statusD E Goodkin, R M Ransohoff, R A RudickCleveland Clinic Journal of Medicine|May 1, 1992
Pharmacotherapy of multiple sclerosis: current statusR A Rudick, D E Goodkin, R M RansohoffArchives of Neurology|August 1, 1991
Diagnostic criteria for multiple sclerosis research involving multiply affected familiesD E Goodkin, T H Doolittle, S S Hauser, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1995
Biologic effects of interferons: relevance to multiple sclerosisR A Rudick, R M RansohoffArchives of Neurology|March 1, 1992
Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activityR A Rudick, R M RansohoffArchives of Neurology|October 1, 1989
Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trialsD E Goodkin, D Hertsgaard, R A RudickCurrent Opinion in Neurology|June 1, 1994
Advances in specific therapy for multiple sclerosisL Jacobs, D E Goodkin, R A Rudick, et al.Applied Nursing Research : ANR|May 1, 1996
Relationships among illness uncertainty, stress, coping, and emotional well-being at entry into a clinical drug trialN M Wineman, K M Schwetz, D E Goodkin, et al.Journal of Neuroimmunology|April 1, 1992
Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivoR M Ransohoff, V K Tuohy, B P Barna, et al.Archives of Neurology|December 1, 1990
Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imagingM L Estes, R A Rudick, G H Barnett, et al.Pageof 25